Cargando…

Linking inherent O-Linked Protein Glycosylation of YghJ to Increased Antigen Potential

Enterotoxigenic Escherichia coli (ETEC) is a WHO priority pathogen and vaccine target which causes infections in low-income and middle-income countries, travelers visiting endemic regions. The global urgent demand for an effective preventive intervention has become more pressing as ETEC strains have...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorsing, Mette, Krogh, Thøger Jensen, Vitved, Lars, Nawrocki, Arkadiusz, Jakobsen, Rikke, Larsen, Martin R., Chakraborty, Subhra, Bourgeois, A. Louis, Andersen, Ann Zahle, Boysen, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417355/
https://www.ncbi.nlm.nih.gov/pubmed/34490144
http://dx.doi.org/10.3389/fcimb.2021.705468
_version_ 1783748362855514112
author Thorsing, Mette
Krogh, Thøger Jensen
Vitved, Lars
Nawrocki, Arkadiusz
Jakobsen, Rikke
Larsen, Martin R.
Chakraborty, Subhra
Bourgeois, A. Louis
Andersen, Ann Zahle
Boysen, Anders
author_facet Thorsing, Mette
Krogh, Thøger Jensen
Vitved, Lars
Nawrocki, Arkadiusz
Jakobsen, Rikke
Larsen, Martin R.
Chakraborty, Subhra
Bourgeois, A. Louis
Andersen, Ann Zahle
Boysen, Anders
author_sort Thorsing, Mette
collection PubMed
description Enterotoxigenic Escherichia coli (ETEC) is a WHO priority pathogen and vaccine target which causes infections in low-income and middle-income countries, travelers visiting endemic regions. The global urgent demand for an effective preventive intervention has become more pressing as ETEC strains have become increasingly multiple antibiotic resistant. However, the vaccine development pipeline has been slow to address this urgent need. To date, vaccine development has focused mainly on canonical antigens such as colonization factors and expressed toxins but due to genomic plasticity of this enteric pathogen, it has proven difficult to develop effective vaccines. In this study, we investigated the highly conserved non-canonical vaccine candidate YghJ/SsLE. Using the mass spectrometry-based method BEMAP, we demonstrate that YghJ is hyperglycosylated in ETEC and identify 54 O-linked Set/Thr residues within the 1519 amino acid primary sequence. The glycosylation sites are evenly distributed throughout the sequence and do not appear to affect the folding of the overall protein structure. Although the glycosylation sites only constitute a minor subpopulation of the available epitopes, we observed a notable difference in the immunogenicity of the glycosylated YghJ and the non-glycosylated protein variant. We can demonstrate by ELISA that serum from patients enrolled in an ETEC H10407 controlled infection study are significantly more reactive with glycosylated YghJ compared to the non-glycosylated variant. This study provides an important link between O-linked glycosylation and the relative immunogenicity of bacterial proteins and further highlights the importance of this observation in considering ETEC proteins for inclusion in future broad coverage subunit vaccine candidates.
format Online
Article
Text
id pubmed-8417355
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-84173552021-09-05 Linking inherent O-Linked Protein Glycosylation of YghJ to Increased Antigen Potential Thorsing, Mette Krogh, Thøger Jensen Vitved, Lars Nawrocki, Arkadiusz Jakobsen, Rikke Larsen, Martin R. Chakraborty, Subhra Bourgeois, A. Louis Andersen, Ann Zahle Boysen, Anders Front Cell Infect Microbiol Cellular and Infection Microbiology Enterotoxigenic Escherichia coli (ETEC) is a WHO priority pathogen and vaccine target which causes infections in low-income and middle-income countries, travelers visiting endemic regions. The global urgent demand for an effective preventive intervention has become more pressing as ETEC strains have become increasingly multiple antibiotic resistant. However, the vaccine development pipeline has been slow to address this urgent need. To date, vaccine development has focused mainly on canonical antigens such as colonization factors and expressed toxins but due to genomic plasticity of this enteric pathogen, it has proven difficult to develop effective vaccines. In this study, we investigated the highly conserved non-canonical vaccine candidate YghJ/SsLE. Using the mass spectrometry-based method BEMAP, we demonstrate that YghJ is hyperglycosylated in ETEC and identify 54 O-linked Set/Thr residues within the 1519 amino acid primary sequence. The glycosylation sites are evenly distributed throughout the sequence and do not appear to affect the folding of the overall protein structure. Although the glycosylation sites only constitute a minor subpopulation of the available epitopes, we observed a notable difference in the immunogenicity of the glycosylated YghJ and the non-glycosylated protein variant. We can demonstrate by ELISA that serum from patients enrolled in an ETEC H10407 controlled infection study are significantly more reactive with glycosylated YghJ compared to the non-glycosylated variant. This study provides an important link between O-linked glycosylation and the relative immunogenicity of bacterial proteins and further highlights the importance of this observation in considering ETEC proteins for inclusion in future broad coverage subunit vaccine candidates. Frontiers Media S.A. 2021-08-19 /pmc/articles/PMC8417355/ /pubmed/34490144 http://dx.doi.org/10.3389/fcimb.2021.705468 Text en Copyright © 2021 Thorsing, Krogh, Vitved, Nawrocki, Jakobsen, Larsen, Chakraborty, Bourgeois, Andersen and Boysen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Thorsing, Mette
Krogh, Thøger Jensen
Vitved, Lars
Nawrocki, Arkadiusz
Jakobsen, Rikke
Larsen, Martin R.
Chakraborty, Subhra
Bourgeois, A. Louis
Andersen, Ann Zahle
Boysen, Anders
Linking inherent O-Linked Protein Glycosylation of YghJ to Increased Antigen Potential
title Linking inherent O-Linked Protein Glycosylation of YghJ to Increased Antigen Potential
title_full Linking inherent O-Linked Protein Glycosylation of YghJ to Increased Antigen Potential
title_fullStr Linking inherent O-Linked Protein Glycosylation of YghJ to Increased Antigen Potential
title_full_unstemmed Linking inherent O-Linked Protein Glycosylation of YghJ to Increased Antigen Potential
title_short Linking inherent O-Linked Protein Glycosylation of YghJ to Increased Antigen Potential
title_sort linking inherent o-linked protein glycosylation of yghj to increased antigen potential
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417355/
https://www.ncbi.nlm.nih.gov/pubmed/34490144
http://dx.doi.org/10.3389/fcimb.2021.705468
work_keys_str_mv AT thorsingmette linkinginherentolinkedproteinglycosylationofyghjtoincreasedantigenpotential
AT kroghthøgerjensen linkinginherentolinkedproteinglycosylationofyghjtoincreasedantigenpotential
AT vitvedlars linkinginherentolinkedproteinglycosylationofyghjtoincreasedantigenpotential
AT nawrockiarkadiusz linkinginherentolinkedproteinglycosylationofyghjtoincreasedantigenpotential
AT jakobsenrikke linkinginherentolinkedproteinglycosylationofyghjtoincreasedantigenpotential
AT larsenmartinr linkinginherentolinkedproteinglycosylationofyghjtoincreasedantigenpotential
AT chakrabortysubhra linkinginherentolinkedproteinglycosylationofyghjtoincreasedantigenpotential
AT bourgeoisalouis linkinginherentolinkedproteinglycosylationofyghjtoincreasedantigenpotential
AT andersenannzahle linkinginherentolinkedproteinglycosylationofyghjtoincreasedantigenpotential
AT boysenanders linkinginherentolinkedproteinglycosylationofyghjtoincreasedantigenpotential